» Articles » PMID: 38769022

Towards Consistency in Pediatric Brain Tumor Measurements: Challenges, Solutions, and the Role of Artificial Intelligence-based Segmentation

Abstract

MR imaging is central to the assessment of tumor burden and changes over time in neuro-oncology. Several response assessment guidelines have been set forth by the Response Assessment in Pediatric Neuro-Oncology (RAPNO) working groups in different tumor histologies; however, the visual delineation of tumor components using MRIs is not always straightforward, and complexities not currently addressed by these criteria can introduce inter- and intra-observer variability in manual assessments. Differentiation of non-enhancing tumors from peritumoral edema, mild enhancement from absence of enhancement, and various cystic components can be challenging; particularly given a lack of sufficient and uniform imaging protocols in clinical practice. Automated tumor segmentation with artificial intelligence (AI) may be able to provide more objective delineations, but rely on accurate and consistent training data created manually (ground truth). Herein, this paper reviews existing challenges and potential solutions to identifying and defining subregions of pediatric brain tumors (PBTs) that are not explicitly addressed by current guidelines. The goal is to assert the importance of defining and adopting criteria for addressing these challenges, as it will be critical to achieving standardized tumor measurements and reproducible response assessment in PBTs, ultimately leading to more precise outcome metrics and accurate comparisons among clinical studies.

Citing Articles

Current state and promise of user-centered design to harness explainable AI in clinical decision-support systems for patients with CNS tumors.

Prince E, Mirsky D, Hankinson T, Gorg C Front Radiol. 2025; 4:1433457.

PMID: 39872709 PMC: 11769936. DOI: 10.3389/fradi.2024.1433457.


Automated pediatric brain tumor imaging assessment tool from CBTN: Enhancing suprasellar region inclusion and managing limited data with deep learning.

Gandhi D, Khalili N, Familiar A, Gottipati A, Khalili N, Tu W Neurooncol Adv. 2024; 6(1):vdae190.

PMID: 39717438 PMC: 11664259. DOI: 10.1093/noajnl/vdae190.


Advancing Pediatric Neuro-Oncology: Multi-institutional nnU-Net Segmentation of Medulloblastoma.

Rudie J, Correia de Verdier M Radiol Artif Intell. 2024; 6(5):e240517.

PMID: 39298570 PMC: 11427924. DOI: 10.1148/ryai.240517.


CAR T cell therapy for pediatric central nervous system tumors: a review of the literature and current North American trials.

Ronsley R, Bertrand K, Song E, Timpanaro A, Choe M, Tlais D Cancer Metastasis Rev. 2024; 43(4):1205-1216.

PMID: 39251462 PMC: 11554695. DOI: 10.1007/s10555-024-10208-4.

References
1.
Del Baldo G, Carai A, Abbas R, Cacchione A, Vinci M, Di Ruscio V . Targeted therapy for pediatric diffuse intrinsic pontine glioma: a single-center experience. Ther Adv Med Oncol. 2022; 14:17588359221113693. PMC: 9459464. DOI: 10.1177/17588359221113693. View

2.
Tak D, Ye Z, Zapaischykova A, Zha Y, Boyd A, Vajapeyam S . Noninvasive Molecular Subtyping of Pediatric Low-Grade Glioma with Self-Supervised Transfer Learning. Radiol Artif Intell. 2024; 6(3):e230333. PMC: 11140508. DOI: 10.1148/ryai.230333. View

3.
Warren K, Vezina G, Poussaint T, Warmuth-Metz M, Chamberlain M, Packer R . Response assessment in medulloblastoma and leptomeningeal seeding tumors: recommendations from the Response Assessment in Pediatric Neuro-Oncology committee. Neuro Oncol. 2017; 20(1):13-23. PMC: 5761545. DOI: 10.1093/neuonc/nox087. View

4.
Jaju A, Li Y, Dahmoush H, Gottardo N, Laughlin S, Mirsky D . Imaging of pediatric brain tumors: A COG Diagnostic Imaging Committee/SPR Oncology Committee/ASPNR White Paper. Pediatr Blood Cancer. 2022; 70 Suppl 4:e30147. PMC: 10466217. DOI: 10.1002/pbc.30147. View

5.
Albert N, Galldiks N, Ellingson B, van den Bent M, Chang S, Cicone F . PET-based response assessment criteria for diffuse gliomas (PET RANO 1.0): a report of the RANO group. Lancet Oncol. 2024; 25(1):e29-e41. PMC: 11787868. DOI: 10.1016/S1470-2045(23)00525-9. View